Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRNX is expected to report earnings to rise 5.37% to -92 cents per share on May 08

Crinetics Pharmaceuticals CRNX Stock Earnings Reports

Q1'25

Est.

$-0.93

Q4'24

Est.

$-0.88

Q3'24

Missed

by $0.05

Q2'24

Missed

by $0.08

Q1'24

Missed

by $0.13

The last earnings report on February 27 showed earnings per share of -87 cents, meeting the estimate of -87 cents. With 558.44K shares outstanding, the current market capitalization sits at 2.85B.

View a ticker or compare two or three

Compare

CRNX